These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 26592202

  • 1. Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide.
    Okuyama-Dobashi K, Kasai H, Tanaka T, Yamashita A, Yasumoto J, Chen W, Okamoto T, Maekawa S, Watashi K, Wakita T, Ryo A, Suzuki T, Matsuura Y, Enomoto N, Moriishi K.
    Sci Rep; 2015 Nov 23; 5():17047. PubMed ID: 26592202
    [Abstract] [Full Text] [Related]

  • 2. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
    Li J, Zong L, Sureau C, Barker L, Wands JR, Tong S.
    J Virol; 2016 Sep 15; 90(18):8302-13. PubMed ID: 27384660
    [Abstract] [Full Text] [Related]

  • 3. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.
    Iwamoto M, Watashi K, Tsukuda S, Aly HH, Fukasawa M, Fujimoto A, Suzuki R, Aizaki H, Ito T, Koiwai O, Kusuhara H, Wakita T.
    Biochem Biophys Res Commun; 2014 Jan 17; 443(3):808-13. PubMed ID: 24342612
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
    Nkongolo S, Ni Y, Lempp FA, Kaufman C, Lindner T, Esser-Nobis K, Lohmann V, Mier W, Mehrle S, Urban S.
    J Hepatol; 2014 Apr 17; 60(4):723-31. PubMed ID: 24295872
    [Abstract] [Full Text] [Related]

  • 5. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
    König A, Döring B, Mohr C, Geipel A, Geyer J, Glebe D.
    J Hepatol; 2014 Oct 17; 61(4):867-75. PubMed ID: 24845614
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
    Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Fälth M, Stindt J, Königer C, Nassal M, Kubitz R, Sültmann H, Urban S.
    Gastroenterology; 2014 Apr 17; 146(4):1070-83. PubMed ID: 24361467
    [Abstract] [Full Text] [Related]

  • 7. N-Linked Glycosylation Is Not Essential for Sodium Taurocholate Cotransporting Polypeptide To Mediate Hepatitis B Virus Infection In Vitro.
    Lee J, Zong L, Krotow A, Qin Y, Jia L, Zhang J, Tong S, Li J.
    J Virol; 2018 Aug 01; 92(15):. PubMed ID: 29793953
    [Abstract] [Full Text] [Related]

  • 8. NTCP opens the door for hepatitis B virus infection.
    Yan H, Liu Y, Sui J, Li W.
    Antiviral Res; 2015 Sep 01; 121():24-30. PubMed ID: 26071008
    [Abstract] [Full Text] [Related]

  • 9. Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity.
    Wang XJ, Hu W, Zhang TY, Mao YY, Liu NN, Wang SQ.
    Antiviral Res; 2015 Aug 01; 120():140-6. PubMed ID: 26086883
    [Abstract] [Full Text] [Related]

  • 10. NTCP-Reconstituted In Vitro HBV Infection System.
    Sun Y, Qi Y, Peng B, Li W.
    Methods Mol Biol; 2017 Aug 01; 1540():1-14. PubMed ID: 27975303
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide.
    Nio Y, Akahori Y, Okamura H, Watashi K, Wakita T, Hijikata M.
    Biochem Biophys Res Commun; 2018 Jun 27; 501(3):820-825. PubMed ID: 29723527
    [Abstract] [Full Text] [Related]

  • 12. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
    Yan H, Peng B, Liu Y, Xu G, He W, Ren B, Jing Z, Sui J, Li W.
    J Virol; 2014 Mar 27; 88(6):3273-84. PubMed ID: 24390325
    [Abstract] [Full Text] [Related]

  • 13. A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection.
    Ueda Y, Gu W, Dansako H, Nishitsuji H, Satoh S, Shimotohno K, Kato N.
    Biochem Biophys Res Commun; 2019 Jul 12; 515(1):156-162. PubMed ID: 31133379
    [Abstract] [Full Text] [Related]

  • 14. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.
    König A, Yang J, Jo E, Park KHP, Kim H, Than TT, Song X, Qi X, Dai X, Park S, Shum D, Ryu WS, Kim JH, Yoon SK, Park JY, Ahn SH, Han KH, Gerlich WH, Windisch MP.
    J Hepatol; 2019 Aug 12; 71(2):289-300. PubMed ID: 31077792
    [Abstract] [Full Text] [Related]

  • 15. Interleukin 6 inhibits HBV entry through NTCP down regulation.
    Bouezzedine F, Fardel O, Gripon P.
    Virology; 2015 Jul 12; 481():34-42. PubMed ID: 25765005
    [Abstract] [Full Text] [Related]

  • 16. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
    Qiao L, Sui J, Luo G.
    J Virol; 2018 Dec 01; 92(23):. PubMed ID: 30232184
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Woodchuck sodium taurocholate cotransporting polypeptide supports low-level hepatitis B and D virus entry.
    Fu L, Hu H, Liu Y, Jing Z, Li W.
    Virology; 2017 May 01; 505():1-11. PubMed ID: 28213271
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.